Valuation: Omnicell, Inc.

Market Cap 1.64B 1.42B 1.33B 1.21B 2.28B 157B 2.31B 15.64B 6.13B 78.63B 6.16B 6.03B 262B P/E 2026 *
36.6x
P/E 2027 * 35.5x
Enterprise Value 1.64B 1.42B 1.33B 1.21B 2.28B 157B 2.31B 15.64B 6.13B 78.63B 6.16B 6.03B 262B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.27x
Free-Float
76.33%
Yield 2026 *
-
Yield 2027 * -
1 day-0.17%
1 week-2.41%
Current month+1.70%
1 month-21.58%
3 months-16.77%
6 months-6.84%
Current year-20.60%
1 week 35.75
Extreme 35.75
37.96
1 month 34.86
Extreme 34.86
45.97
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
61.44
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 30/09/2002
Director of Finance/CFO 56 14/09/2025
President 50 30/06/2026
Director TitleAgeSince
Chairman 68 31/08/1992
Director/Board Member 70 31/12/2012
Director/Board Member 70 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Sell

Chief Executive Officer

-10,000 0.0220%
01/07/26 Free

Chairperson

12,309 0.0271%
01/04/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-2.41%+13.79%-38.48% 1.64B
+1.85%+2.61%-13.95%+29.83% 39.43B
+1.07%+9.46%-37.47%+179.48% 14.58B
-1.38%-0.14%-20.70%+66.13% 5.72B
+7.84%+53.11%+50.92% - 3.93B
+2.49%+12.68% - - 2.06B
+12.47%+9.28%-36.33% - 976M
+2.76%+3.64%+43.20%+134.95% 958M
-2.22%-4.08%-35.93%-45.69% 811M
-1.64%-9.64%+631.71%+867.74% 800M
Average +2.31%+7.62%+66.14%+170.57% 7.09B
Weighted average by Cap. +1.81%+6.69%-7.41%+76.55%

Financials

2026 *2027 *
Net sales 1.24B 1.07B 1.01B 914M 1.72B 119B 1.74B 11.79B 4.62B 59.27B 4.64B 4.54B 197B 1.29B 1.11B 1.05B 951M 1.79B 123B 1.82B 12.28B 4.81B 61.73B 4.84B 4.73B 206B
Net income 45.27M 39.1M 36.79M 33.44M 62.89M 4.34B 63.81M 432M 169M 2.17B 170M 166M 7.23B 47.37M 40.91M 38.49M 34.98M 65.8M 4.54B 66.76M 452M 177M 2.27B 178M 174M 7.56B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
18/08/26 US$35.97 -0.17% 947,786
17/08/26 US$36.03 -3.40% 887,407
14/08/26 US$37.30 -0.90% 393,557
13/08/26 US$37.64 +1.37% 660,203
12/08/26 US$37.13 +0.73% 742,246
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
35.97USD
Average target price
57.86USD
Spread / Average Target
+60.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock